Titrimetric and Spectrophotometric Assay of Diethylcarbamazine Citrate in Pharmaceuticals using Permanganate as Oxidant
DOI:
https://doi.org/10.37591/(rrjops).v7i3.485Abstract
Two titrimetric and one spectrophotometric methods are described for the determination of diethylcarbamazine citrate in bulk drug and dosage forms using permanganate as an oxidimetric agent. In method A, the drug solution in H2SO4 is titrated directly at 80°C to a pink end-point. DEC was treated with a measured excess of standard permanganate in H2SO4 medium, and after a contact time of 5 min, the residual oxidant back titrated with ammonium ferrous sulphate to a colorless end-point (method B). Spectrophotometry is based on the measurement of the unreacted permanganate at 550 nm after the reaction between DEC and permanganate in H2SO4 medium is ensured to be complete (method C). In all methods, the amount of permanganate reacted was related to the amount/concentration of DEC. Experimental variables associated with the assay were carefully examined and optimized for better performance characteristics. Both the titrimetric methods are applicable over 1–10 mg range and the reaction follows 1:3 and 1:4 (DEC:KMnO4) stoichiometry in direct and indirect methods, respectively. In spectrophotometry, Beer's law is obeyed in the inverse manner, and linearity is observed in the range 2.5–30 µg ml-1 with a molar absorptivity value of 8.03×103 l mol-1 cm-1. The limits of detection (LOD) and quantification (LOQ) were calculated to be 0.12 and 0.35 µg ml-1, respectively. The methods were validated for precision and accuracy, robustness and ruggedness and selectivity. The methods were applied to the determination of DEC in tablets and suspension with satisfactory results. The accuracy of the methods was also assessed by recovery study via standard-addition procedure.
Keywords: Diethylcarbamazine citrate, assay, titrimetry, spectrophotometry, permanganate, pharmaceuticals
Cite this Article
Nagib Qarah AS, Basavaiah K. Titrimetric and Spectrophotometric Assay of Diethylcarbamazine Citrate in Pharmaceuticals using Permanganate as Oxidant. Research and Reviews: A Journal of Pharmaceutical Science. 2016; 7(3): 1–11p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |